SCCM Resource Library-Anticoagulation in CKRT: Are We Spoiled for Choices?

Video Transcription

Video Summary

In this session on Continuous Renal Replacement Therapy (CRRT) for children, Dr. Akash Deep discusses the intricacies of anticoagulation therapy. He underscores the importance of filter life, emphasizing how it enhances CRRT efficacy by minimizing downtime. Anticoagulants like heparin, citrate, and emerging options like prostacyclin, nifemostat mesilate, and their potential in clinical settings were explored. Citrus is popular but complex due to training and complication risks. Prostacyclin, while less known, shows promise with safe, cost-effective regional administration. The presentation notes minimal side effects and effective combination therapy with heparin for inflammation. Additionally, the session touched upon the impact of COVID-19, suggesting adaptive anticoagulation strategies during crises. Overall, he highlights the need for simplified protocols and well-trained staff to ensure effective CRRT delivery.

Asset Caption

One-Hour Concurrent Session | Controversies in the Delivery of Continuous Renal Replacement Therapy in Children

Meta Tag

Content Type Presentation

Membership Level Professional

Membership Level Select

Year 2024

Keywords

CRRT

anticoagulation

heparin

prostacyclin

COVID-19

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.